SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000909661-00-000001
Filing Date
2000-01-10
Accepted
2000-01-10 00:00:00
Documents
1
Group Members
ANDREW B. FREMDERDAVID I. COHENENRIQUE BOILINIFARALLON CAPITAL (CP) INVESTORS, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL MANAGEMENT LL

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 2 SC 13D/A 96617
  Complete submission text file 0000909661-00-000001.txt   99244
Mailing Address ONE MARITIME PLAZA SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLAZA STE 11325 SAN FRANCISCO CA 94111 4154212132
FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279

Mailing Address
Business Address CONYERS DILL & PEARMAN CLARENDON HOUSE 2 CHURCH ST HAMILTON HM 11 BERMU D0 4412951422
AXOGEN LTD (Subject) CIK: 0001026113 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-49831 | Film No.: 504747
SIC: 2834 Pharmaceutical Preparations